This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us to understand which sections of the website you find most interesting and useful.
IR highlights
We are a global provider of X-ray detector solutions and services for medical, security, and industrial applications. Our company’s shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.
Latest releases
Next IR event
Business review January–March 2024 at 9:00 (EEST)
Annual
review
2023
Annual general meeting 2024
The Annual General Meeting was held in Espoo, Finland on Wednesday 27 March 2024 at 15:00.
We offer off-the-shelf and customized X-ray imaging solutions and services for original equipment manufacturers (OEMs) and system integrators. Our solutions meet the performance and reliability requirements of the most stringent applications, such as high-end computed tomography (CT) systems. Over two billion inspections are done daily with our technology, and the number is growing rapidly.
Key figures
104 M€
Total net sales in 2023
9%
EBITA-% in 2023
460
Active customers in over 40 countries
480
Employees in Finland, China, France and the US
Global trends as growth drivers
Ageing populations
boost investments in healthcare.
The growing importance of security
boosts public and private sector investments in security.
The eco economy
boosts X-ray demand as green products and services, such as energy harvesting and
storing, and electric vehicles, become more common.
The circular economy
boosts X-ray demand as recycling and material sorting increase.
Digitalization and AI
boost X-ray usability as data utilization reaches a new level.
Quality and efficiency requirements
boost the use of X-rays in quality assurance of materials, components, and processes.
Emerging markets
boost investments in healthcare and security as purchasing power increases with GDP growth.
Pandemics
boost healthcare investments in developed and emerging countries.
Lack of raw materials
boosts the use of X-rays in the exploitation of scarce discoveries.
Financial targets
MEDIUM-TERM TARGET
Annual
sales growth
>10%
MEDIUM-TERM TARGET
Operating
margin (EBITA)
15%
ANNUAL
Dividend or
returned capital
30-60%
Market outlook
MEDICAL MARKET
Annual
Growth Rate
5%
SECURITY MARKET
Annual
Growth Rate
6%
INDUSTRIAL MARKET
Annual
Growth Rate
5%
Investor contacts
investors@nulldeetee.com
Hannu Martola
President and CEO
+358 500 449 475
hannu.martola@nulldeetee.com
For investor meetings and requests
Johanna Tarkiainen
Director, Marketing and Communications
+358 40 7287 163
johanna.tarkiainen@nulldeetee.com